| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2478098 | Annales Pharmaceutiques Françaises | 2012 | 6 Pages |
Abstract
Tocilizumab can be used in patients with refractory ASD after failure or intolerance of conventional treatments.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
A. Rkiouak, K. Ennibi, A. Zinebi, Y. Akhouad, A. Reggad, M. Rabhi, J. Chaari,